Canada markets open in 2 hours 9 minutes

ImmuPharma plc (IMMPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.08500.0000 (0.00%)
At close: 03:47PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
118.35
118.35
126.667
77.925
81.281
Operating Expenses
Research Development
3,650
3,650
2,373
2,665
4,697
Selling General and Administrative
1,011
1,011
1,765
1,831
1,660
Total Operating Expenses
5,278
5,278
5,716
6,360
8,161
Operating Income or Loss
-5,160
-5,160
-5,589
-6,282
-8,080
Interest Expense
124.063
124.063
230.828
4.045
4.783
Income Before Tax
-8,941
-8,941
-7,246
-6,744
-7,955
Income Tax Expense
-766.814
-766.814
-386.248
-620.774
-748.606
Income from Continuing Operations
-8,174
-8,174
-6,860
-6,124
-7,207
Net Income
-8,174
-8,174
-6,860
-6,124
-7,207
Net Income available to common shareholders
-8,174
-8,174
-6,860
-6,124
-7,207
Basic EPS
-
-
-0.03
-0.04
-0.05
Diluted EPS
-
-
-0.03
-0.04
-0.05
Basic Average Shares
-
-
200,176
153,452
138,840
Diluted Average Shares
-
-
200,176
153,452
138,840
EBITDA
-
-8,703
-6,844
-6,652
-7,817